CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 167 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2014. The put-call ratio across all filers is 2.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $58,000 | -17.1% | 24,688 | 0.0% | 0.00% | – |
| Q4 2017 | $70,000 | -1.4% | 24,688 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $71,000 | +16.4% | 24,688 | 0.0% | 0.00% | – |
| Q2 2017 | $61,000 | -31.5% | 24,688 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $89,000 | +2.3% | 24,688 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $87,000 | -13.0% | 24,688 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $100,000 | -7.4% | 24,688 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $108,000 | +16.1% | 24,688 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $93,000 | -76.0% | 24,688 | 0.0% | 0.00% | -66.7% |
| Q4 2015 | $387,000 | +48.8% | 24,688 | 0.0% | 0.00% | +50.0% |
| Q3 2015 | $260,000 | -58.3% | 24,688 | 0.0% | 0.00% | -60.0% |
| Q2 2015 | $623,000 | -15.5% | 24,688 | -6.7% | 0.01% | -16.7% |
| Q1 2015 | $737,000 | +40.4% | 26,461 | -8.0% | 0.01% | +50.0% |
| Q4 2014 | $525,000 | +40.8% | 28,774 | 0.0% | 0.00% | +33.3% |
| Q3 2014 | $373,000 | -20.6% | 28,774 | 0.0% | 0.00% | -25.0% |
| Q2 2014 | $470,000 | -7.5% | 28,774 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $508,000 | -27.1% | 28,774 | 0.0% | 0.00% | -33.3% |
| Q4 2013 | $697,000 | -31.6% | 28,774 | 0.0% | 0.01% | -33.3% |
| Q3 2013 | $1,019,000 | +71.5% | 28,774 | -24.4% | 0.01% | +50.0% |
| Q2 2013 | $594,000 | – | 38,038 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |